| 31776465 | Bartels S, Faisal M, Büsche G, et al. Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis. Leukemia. 2020.34(5):1364-1372. doi:10.1038/s41375-019-0668-5 |
| 25573593 | Pósfai É, Marton I, Király PA, et al. JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis. Pathol Oncol Res. 2015.21(3):751-758. doi:10.1007/s12253-014-9885-4 |
| 26994960 | Monte-Mor Bda C, Ayres-Silva Jde P, Correia WD, et al. Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis. Blood Cells Mol Dis. 2016.60:74-77. doi:10.1016/j.bcmd.2016.03.003 |
| 25173966 | Turon F, Cervantes F, Colomer D, Baiges A, Hernández-Gea V, Garcia-Pagán JC. Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis. J Hepatol. 2015.62(1):72-74. doi:10.1016/j.jhep.2014.08.032 |
| 24402162 | Tefferi A, Lasho TL, Finke CM, et al. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia. 2014.28(7):1472-1477. doi:10.1038/leu.2014.3 |
| 26377485 | Wang J, Hao J, He N, Ji C, Ma D. The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia. Miyeloproliferatif Neoplazisi ve Akut Lösemisi Olan Hastalarda Kalretikülin Mutasyon Profili. Turk J Haematol. 2016.33(3):180-186. doi:10.4274/tjh.2015.0220 |
| 32971364 | Javorniczky NR, Wehrle J, Ihorst G, et al. Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy. Leuk Res. 2020.98:106454. doi:10.1016/j.leukres.2020.106454 |
| 25838280 | Bonzheim I, Mankel B, Klapthor P, et al. CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation. Blood. 2015.125(14):2309-2311. doi:10.1182/blood-2014-12-616847 |
| 27521277 | Panovska-Stavridis I, Eftimov A, Ivanovski M, et al. Diversities of Calreticulin Gene Mutations in Macedonian Patients With Essential Thrombocythemia. Clin Lymphoma Myeloma Leuk. 2016.16(8):477-481. doi:10.1016/j.clml.2016.04.019 |
| 27352261 | Haslam K, Conneally E, Flynn CM, et al. CALR mutation profile in Irish patients with myeloproliferative neoplasms. Hematol Oncol Stem Cell Ther. 2016.9(3):112-115. doi:10.1016/j.hemonc.2016.05.002 |
| 27855276 | Usseglio F, Beaufils N, Calleja A, Raynaud S, Gabert J. Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia. J Mol Diagn. 2017.19(1):92-98. doi:10.1016/j.jmoldx.2016.08.006 |
| 25637689 | Labastida-Mercado N, Galindo-Becerra S, Garcés-Eisele J, et al. The mutation profile of JAK2, MPL and CALR in Mexican patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Hematol Oncol Stem Cell Ther. 2015.8(1):16-21. doi:10.1016/j.hemonc.2014.12.002 |
| 27535857 | Xu ZF, Li B, Liu JQ, et al. Zhonghua Xue Ye Xue Za Zhi. 2016.37(7):576-580. doi:10.3760/cma.j.issn.0253-2727.2016.07.007 |
| 25103987 | Trifa AP, Popp RA, Cucuianu A, et al. CALR versus JAK2 mutated essential thrombocythaemia - a report on 141 patients. Br J Haematol. 2015.168(1):151-153. doi:10.1111/bjh.13076 |
| 29148089 | Venton G, Courtier F, Charbonnier A, et al. Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms. Am J Hematol. 2018.93(3):330-338. doi:10.1002/ajh.24973 |
| 25661444 | Mondet J, Park JH, Menard A, et al. Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia. Haematologica. 2015.100(5):e176-e178. doi:10.3324/haematol.2014.118927 |